Literature DB >> 7895211

Lifetime probability of developing lung cancer, by smoking status, Canada.

P J Villeneuve1, Y Mao.   

Abstract

Life table methodology was used to estimate the probability of developing lung cancer by smoking status. Lifetime risks of developing lung cancer were estimated for six hypothetical cohorts (males, females, male current smokers, male never smokers, female current smokers, and female never smokers). Estimates of smoking mortality and incidence rates were calculated based on Canadian rates observed over the period 1987 to 1989. It was found that 172/1,000 of male current smokers will eventually develop lung cancer; the similar probability among female current smokers was 116/1,000. For those who never smoked on a regular basis the lifetime risk was substantially reduced. Only 13/1,000 males and 14/1,000 females in this category will develop lung cancer. When smoking status is not adjusted for, the lifetime risk of developing lung cancer is approximately 96/1,000 and 43/1,000 for males and females respectively.

Entities:  

Mesh:

Year:  1994        PMID: 7895211

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  26 in total

1.  Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.

Authors:  Wusheng Yan; Ignacio I Wistuba; Michael R Emmert-Buck; Heidi S Erickson
Journal:  Am J Cancer Res       Date:  2011-01-01       Impact factor: 6.166

2.  New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer.

Authors:  Anna Chikova; Hans-Ulrich Bernard; Igor B Shchepotin; Sergei A Grando
Journal:  Life Sci       Date:  2012-01-17       Impact factor: 5.037

3.  Actein inhibits cell proliferation and migration and promotes cell apoptosis in human non-small cell lung cancer cells.

Authors:  Yuanyuan Zhang; Jianchun Lian; Xiaowei Wang
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

4.  Biological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: A case-control study in Japan.

Authors:  Yuzo Yamamoto; Chikako Kiyohara; Saiko Suetsugu-Ogata; Naoki Hamada; Yoichi Nakanishi
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

Review 5.  Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.

Authors:  Matthijs Oudkerk; ShiYuan Liu; Marjolein A Heuvelmans; Joan E Walter; John K Field
Journal:  Nat Rev Clin Oncol       Date:  2020-10-12       Impact factor: 66.675

6.  Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer.

Authors:  Shama C Buch; Brenda Diergaarde; Tomoko Nukui; Roger S Day; Jill M Siegfried; Marjorie Romkes; Joel L Weissfeld
Journal:  Mol Carcinog       Date:  2011-10-04       Impact factor: 4.784

7.  Estimation of odds ratios of genetic variants for the secondary phenotypes associated with primary diseases.

Authors:  Jian Wang; Sanjay Shete
Journal:  Genet Epidemiol       Date:  2011-02-09       Impact factor: 2.135

8.  Analysis of occupational asbestos exposure and lung cancer mortality using the g formula.

Authors:  Stephen R Cole; David B Richardson; Haitao Chu; Ashley I Naimi
Journal:  Am J Epidemiol       Date:  2013-04-04       Impact factor: 4.897

9.  Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer.

Authors:  Yonggang He; Yilei Gong; Jie Lin; David W Chang; Jian Gu; Jack A Roth; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-08       Impact factor: 4.254

10.  An ecological approach to examine lung cancer disparities due to sexual orientation.

Authors:  U Boehmer; A Ozonoff; X Miao
Journal:  Public Health       Date:  2012-05-11       Impact factor: 2.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.